Hydroxy-L-tyrosine methyl ester, 3-
Hydroxy-L-tyrosine methyl ester, 3-
$65.00 - 5 mg
$230.00 - 25 mg
All prices in Australian dollars
- Code
- BIA-H2603
- Synonyms
- 3,4-Dihydroxyphenyl-L-alanine methyl ester hydrochloride, 3-Hydroxy-L-tyrosine methyl ester hydrochloride, L-DOPA Me ester hydrochloride, L-Dopa methyl ester hydrochloride, Levodopa methyl ester hydrochloride, Methyl L-3-(3,4-dihydroxyphenyl)alaninate hydrochloride, ST 41769
- CAS #
- 1421-65-4
- Molecular Formula
- C10H13NO4
- Molecular Weight
- 211.2
- Purity
- >95% by HPLC
- Long Term Storage
- -20°C
- Solubility
- Soluble in methanol or DMSO
Download Data Sheets
Application Notes
3-Hydroxy-L-tyrosine methyl ester (melevodopa, L-dopa methyl ester) is a prodrug of levodopa used for the treatment of Parkinson’s disease. L-DOPA methyl ester is a potent competitive antagonist for the action of L-DOPA. Short-term exposure to L-DOPA methyl ester inhibits the induction of endogenous xenotropic type-C virus from Kirsten sarcoma-virus-transformed BALB/c (K-BALB) mouse cells. L-DOPA methyl ester has weak activity against against L1210 and P388 murine leukaemias and B-16 melanoma cell lines.
References
- Available and emerging treatments for Parkinson’s disease: a review. Drug Design Dev. 2011, 5, 241.
- L-dopa methyl ester antagonizes competitively L-dopa-induced facilitation of noradrenaline release from rat hypothalamic slices. Goshima Y. et al. Japan J Pharmacol. 1990, 52, 174.
- Inhibition of endogenous murine retrovirus expression by L-β-3,4-dihydroxyphenylalanine (L-dopa) methyl ester. Suk W.A. et al. Int J Cancer 1981, 27, 37.